NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
11/21/2023
Back to search
Official data from USPTO
PHARMASPECTRA LINK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMASPECTRA LINK
ST13
US500000090618037Class
42
Filing
90618037
Registration
6645997
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
11/21/2023
Trademark type
Word
Nice classes
42
Filing date
04/01/2021
Registration date
02/15/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/15/2022
Last transaction
02/27/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
12/31/2014
First use in commerce
12/31/2014
Drawing code
4
Owner type
99
Owner location
London, GB
Examiner
PURATH,ANICKA S
Law office
L10
Current location
TMEG LAW OFFICE 101
Holders and representatives
Holders
Pharmaspectra Group LTD
Representatives
Cynthia Johnson Walden Fish & Richardson P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Platform as a service (PaaS) featuring computer software platforms for collectingstoringanalyzinggenerating reports and profiles on individuals based on information and data from third party research grantsclinical trialspatentspublications and conferences in the field of medical affairs
Publications
History of USPTO decisions and trademark events.
20 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
10/19/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/10/2023
ES7R
TEAS SECTION 7 REQUEST RECEIVED
02/24/2023
NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
11/29/2022
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
10/26/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/24/2022
ES7R
TEAS SECTION 7 REQUEST RECEIVED
05/24/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
02/15/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/30/2021
PUBO
PUBLISHED FOR OPPOSITION
11/30/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/21/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
10/21/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/21/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
10/21/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/21/2021
DOCK
ASSIGNED TO EXAMINER
10/20/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/09/2021
NWAP
NEW APPLICATION ENTERED
04/05/2021
Continuous trademark protection
Get notified about every new filing that threatens PHARMASPECTRA LINK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.